You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GnRH agonist

Showing 2201 - 2209 of 2,209
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Opioid-Related Disorders Trial in Burlington (Buprenorphine)

Completed
  • Opioid-Related Disorders
  • Burlington, Vermont
    Treatment Research Center
Jun 23, 2005

Opioid-Related Disorders Trial in Burlington (Buprenorphine)

Completed
  • Opioid-Related Disorders
  • Burlington, Vermont
    Treatment Research Center
Jun 23, 2005

Opioid-Related Disorders Trial in Burlington (Buprenorphine)

Completed
  • Opioid-Related Disorders
  • Burlington, Vermont
    Treatment Research Center
Jun 23, 2005

Tourette Syndrome Trial (guanfacine)

Completed
  • Tourette Syndrome
  • (no location specified)
Jun 23, 2005

Opioid-Related Disorders Trial in Burlington (Buprenorphine)

Completed
  • Opioid-Related Disorders
  • Burlington, Vermont
    Treatment Research Center
Jun 23, 2005

Orthostatic Hypotension Trial in New York (midodrine)

Completed
  • Orthostatic Hypotension
  • New York, New York
    Mount Sinai School of Medicine
Jun 23, 2005

Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

Completed
  • Lipodystrophy
    • Galveston, Texas
      University of Texas Medical Branch
    Jun 23, 2005

    Porphyria Trial in Galveston (luteinizing hormone-releasing factor)

    Completed
    • Porphyria
    • luteinizing hormone-releasing factor
    • Galveston, Texas
      University of Texas Medical Branch
    Jun 23, 2005

    Atrial Fibrillation Trial in Richmond (DTI-0009)

    Completed
    • Atrial Fibrillation
    • Richmond, Virginia
      Multiple locations
    Jun 23, 2005